XENT - Intersect ENT EPS misses by $0.08 beats on revenue; raises outlook

Intersect ENT (XENT): Q1 Non-GAAP EPS of -$0.51 misses by $0.08; GAAP EPS of -$0.61 misses by $0.21.Revenue of $24.3M (+22.5% Y/Y) beats by $0.76M.Intersect ENT is raising its full year 2021 revenue guidance from a range of $116 million - $120 million to a range of $117 million - $121 million vs. consensus of $119.37M; gross margin is expected to be in the low-to-mid 70s. Based on current expectations of the operating environment in 2021 and 2022, the Company believes it has adequate cash and other resources to operate well into 2022.Press Release

For further details see:

Intersect ENT EPS misses by $0.08, beats on revenue; raises outlook